Tag: CFSRE

Cannabis and Cannabinoids, Chemistry, Crime Scene Investigation and Reconstruction, Forensic Pathology and Medicolegal Death Investigation, Seized Drugs/Controlled Substances, Toxicology

Q2 2023 Trend Reports – NPS Benzodiazepines, NPS Opioids, NPS Stimulants & Hallucinogens, and Synthetic Cannabinoids in the U.S.

July 18, 2023July 18, 2023 sdargoltz

Alex J. Krotulski, PhD; Sara E. Walton, MS; Amanda L.A. Mohr, MSFS, D-ABFT-FT; and Barry K. Logan, PhD, F-ABFT

CFSRE; July 2023

Recommended Scope for NPS Testing in the United States: Q2, 2023

June 16, 2023June 16, 2023 sdargoltz

Alex Krotulski, Donna Papsun, Dani Mata, Kayla Ellefson, Elisa Shoff, Szabolcs Sofalvi, Svanto Vikingsson, Michael Truver, Celia Modoll, and Barry Logan

CFSRE; May 2023

ToxIC Fentalog Study Group – Quarterly NPS Report: Q2 2023

June 14, 2023 sdargoltz

Alex Manini, Alex Krotulski, Sara Walton, Paul Wax, Jeffery Brent, Kim Aldy, Rachael Culbreth, Joseph Carpenter, Alexandra Amaducci, Jennie Buchanan, Bryan Judge, Michael Levine, Diane Calello, Joshua Shulman, Rob Hendrickson, Adrienne Hughes, Barry Logan

CFSRE; May 2023

ToxIC Fentalog Study Group – Quarterly NPS Report: Q1 2023

June 14, 2023 sdargoltz

CFSRE; May 2023

ADB-5’Br-PINACA – New drug monograph

May 25, 2023May 25, 2023 sdargoltz

Alex J. Krotulski, Osama Abdallah Sharif Alyamani, Maha Elgid, Sara E. Walton, Josh DeBord, Melissa F. Fogarty, and Barry K. Logan

CFSRE; May 1, 2023

NPS Benzodiazepines, NPS Opioids, NPS Stimulants & Hallucinogens, and Synthetic Cannabinoids in the United States – Q1 2023 Trend Report

May 19, 2023May 26, 2023 sdargoltz

Alex J. Krotulski, PhD; Sara E. Walton, MS; Amanda L.A. Mohr, MSFS, D-ABFT-FT; and Barry K. Logan, PhD, F-ABFT

CFSRE; April 2023

Phenylbutazone: A Toxic Adulterant Found in Illicit Street Drugs

April 19, 2023April 20, 2023 sdargoltz

Sarah A. Shuda, M.S., Amanda L.A. Mohr, M.S., Thom Browne, and Barry K. Logan, Ph.D.

CFSRE; March 2023

Evaluation of Xylazine Test Strips (BTNX) for Drug Checking Purposes

March 24, 2023March 24, 2023 Becky Carter

Krotulski, AJ; Shinefeld, J; DeBord, J; Teixeira da Silva, D; Logan, BK.

CFSRE; 2023

Recommended Scope for NPS Testing in the United States: Q1 2023

February 10, 2023February 10, 2023 Becky Carter

Alex Krotulski, Donna Papsun, Dani Mata, Kayla Ellefson, Elisa Shoff, Szabolcs Sofalvi, Svanto Vikingsson, Michael Truver, Celia Modoll, and Barry Logan

SOFT, CFSRE; February 2023

N-Desethyl Isotonitazene

January 3, 2023January 3, 2023 sdargoltz

Alex J. Krotulski, PhD; Reta Newman, MA; Michael Gilbert, BS; Sara E. Walton, MS; Melissa F. Fogarty, MSFS, D-ABFT-FT; and Barry K. Logan, PhD, F-ABFT

CFSRE; December 20, 2022

Drug Checking Quarterly Report – Q3 2022

November 28, 2022November 28, 2022 Becky Carter

Alex J. Krotulski, PhD; Jen Shinefeld, MS; Joshua DeBord, PhD; Daniel Teixeira da Silva, MD; and Barry K. Logan, PhD, F-ABFT

CFSRE, PDPH; November 2022

Chemistry, DREs / Traffic Safety Resource Prosecutors, Seized Drugs/Controlled Substances, Sexual Assault / SANE, Toxicology

ToxIC Fentalog Study Group – Quarterly NPS Report – Q3

November 18, 2022November 18, 2022 sdargoltz

Alex Manini, MD; Alex J Krotulski, PhD; Sara E. Walton, MS; Paul Wax, MD; Jeffery Brent, MD, PhD; Kim Aldy, DO; Alexandra Amaducci, DO; Dlane Calello, MD; Adrienne Hughes, MD; Anthony Pizon, MD; Michael Levine, MD; Evan Schwarz, MD; Bryan Judge, MD; and Barry K. Logan, PhD, F-ABFT

CSFRE; TIC; ACMT; October 2022

NPS Discovery Toolkit: N-Pyrrolidino Etonitazene

November 15, 2022November 16, 2022 sdargoltz

Sara E. Walton, MS; Alex J. Krotulski, PhD; Melissa F. Fogarty, MSFS, D-ABFT-FT; Donna M. Papsun, MS, D-ABFT; and Barry K. Logan, PhD, F-ABFT

CFSRE; October 2022

NPS Benzodiazepines in the United States – Q3 Trend Report

November 15, 2022 sdargoltz

Alex J. Krotulski, PhD; Sara E. Walton, MS; Amanda L.A. Mohr, MSFS, D-ABFT-FT; and Barry K. Logan, PhD, F-ABFT

CFSRE; October 2022

Chemistry, DREs / Traffic Safety Resource Prosecutors, Forensic Pathology and Medicolegal Death Investigation, Seized Drugs/Controlled Substances, Statistics and Data Analysis, Toxicology

Fentanyl Purity, Potency, & Synthesis: Real-Time Testing of Opioid Drug Products in the United States

August 25, 2022August 25, 2022 sdargoltz

Krotulski, AJ, Shinefeld, J, DeBord, J, Logan, BK

CFSRE; August, 2022

Recommended Scope for NPS Testing in the United States: Q2 2022

July 27, 2022July 27, 2022 sdargoltz

Alex Krotulski, Donna Papsun, Dani Mata, Kayla Ellefsen, Elisa Shoff, Kevin Shanks, Szabolcs Sofalvi, Wayne Lewallen, Svante Vikingsson, and Barry Logan

CFSRE; July 2022

N-Propyl Butylone

July 25, 2022 sdargoltz

Alex J. Krotulski, PhD; Vanquilla Shellman Francis, PhD; Melissa F. Fogarty, MSFS, D-ABFTFT; Sara E. Walton, MS; and Barry K. Logan, PhD, F-ABFT

CFSRE; July 21, 2022

Crime Scene Investigation and Reconstruction, DREs / Traffic Safety Resource Prosecutors, Forensic Pathology and Medicolegal Death Investigation, Seized Drugs/Controlled Substances, Toxicology

NPS Benzodiazepines, NPS Opioids, NPS Stimulants & Hallucinogens, and Synthetic Cannabinoids – Q2 2022 Trend Reports

July 19, 2022July 19, 2022 sdargoltz

Alex J. Krotulski, PhD; Sara E. Walton, MS; Amanda L.A. Mohr, MSFS, D-ABFT-FT; and Barry K. Logan, PhD, F-ABFT

CFSRE; July 13, 2022

CH-FUBIATA

July 1, 2022July 1, 2022 sdargoltz

Alex J. Krotulski, PhD; Jennifer Shinefeld, MS; Melissa F. Fogarty, MSFS, D-ABFT-FT; Joshua DeBord, PhD; and Barry K. Logan, PhD, F-ABFT

CFSRE; June 21, 2022

Cannabis and Cannabinoids, Crime Scene Investigation and Reconstruction, DREs / Traffic Safety Resource Prosecutors, Forensic Pathology and Medicolegal Death Investigation, Seized Drugs/Controlled Substances, Toxicology

Bromazolam Prevalence Surging Across the United States Driven In Part by Increasing Detections Alongside Fentanyl

June 28, 2022June 28, 2022 sdargoltz

Donna M. Papsun, MS, D-ABFT-FT; Alex J. Krotulski, PhD; Rebecca Mastrovito, MS; Sara E. Walton, MS; and Barry K. Logan, PhD, F-ABFT

CFSRE; June 15, 2022

N-Cyclohexyl Butylone

June 27, 2022June 27, 2022 sdargoltz

Alex J. Krotulski, PhD; Vanquilla Shellman Francis, PhD; Ryan Farrell; Zackery Roberson, PhD; Melissa F. Fogarty, MSFS, D-ABFT-FT; Sara E. Walton, MS; and Barry K. Logan, PhD, F-ABFT

CFSRE; June 9, 2022

Drug Checking (Q2 2022): Philadelphia, Pennsylvania, USA

June 24, 2022June 24, 2022 Becky Carter

Alex J. Krotulski, PhD; Jen Shinefeld, MS; Jeffrey Hom, MD, MPH; Sara E. Walton, BS; Joshua DeBord, PhD; Barry K. Logan, PhD, F-ABFT

CFSRE; June 7, 2022

ADB-5’Br-BINACA

May 31, 2022June 24, 2022 Becky Carter

Alex J. Krotulski, PhD; Jennifer Shinefeld, MS; Robert M. Schelkun, MS; Donna M. Iula, PhD; Melissa F. Fogarty, MSFS, D-ABFT-FT; Joshua DeBord, PhD; and Barry K. Logan, PhD, F-ABFT

CFSRE; May 26, 2022

BZO-4en-POXIZID

May 23, 2022May 23, 2022 Becky Carter

Alex J. Krotulski, PhD; Ryan Farrell; Armando Vargas; Melissa F. Fogarty, MSFS, DABFT-FT; Sara E. Walton, MS; and Barry K. Logan, PhD, F-ABF

CFSRE; May 19, 2022

Chemistry, Crime Scene Investigation and Reconstruction, DREs / Traffic Safety Resource Prosecutors, Seized Drugs/Controlled Substances, Toxicology

Recommended Scope for NPS Testing in the United States – Q1 2022

May 23, 2022May 23, 2022 Becky Carter

Alex Krotulski, Donna Papsun, Dani Mata, Kayla Ellefsen, Elisa Shoff, Kevin Shanks, Szabolcs Sofalvi, Wayne Lewallen, Svante Vikingsson, and Barry Logan

CFSRE; May 12, 2022

N-Cyclohexyl Methylone

May 23, 2022 Becky Carter

Alex J. Krotulski, PhD; Vanquilla Shellman Francis, PhD; Ryan Farrell; Kaitlin Schilde, MSFS; Melissa F. Fogarty, MSFS, D-ABFT-FT; Sara E. Walton, MS; and Barry K. Logan, PhD, F-ABFT

CFSRE; May 9, 2022

ADB-5Br-INACA

May 18, 2022May 26, 2022 Becky Carter

Alex J. Krotulski, PhD; Ryan Farrell; Zackery Roberson, PhD; Melissa F. Fogarty, MSFS, D-ABFT-FT; Sara E. Walton, MS; and Barry K. Logan, PhD, F-ABFT

CFSRE; May 17, 2022

MDMB-5Br-INACA

May 18, 2022 Becky Carter

Alex J. Krotulski, PhD; Ryan Farrell; Kaitlin Schilde, MSFS; Melissa F. Fogarty, MSFS, D-ABFT-FT; Sara E. Walton, MS; and Barry K. Logan, PhD, F-ABFT

CFSRE; May 17, 2022

CH-PIATA

May 2, 2022May 2, 2022 Becky Carter

Alex J. Krotulski, PhD; Ryan Farrell; Amanda Mohaupt, MSFS; Melissa F. Fogarty, MSFS, D-ABFT-FT; Sara E. Walton, MS; and Barry K. Logan, PhD, F-ABFT

CFSRE; April 29, 2022

Synthetic Stimulant Market Rapidly Changing as N,N-Dimethylpentylone Replaces Eutylone in Drug Supply Typically Sold as “Ecstasy” or “Molly”

April 22, 2022 Becky Carter

Alex J. Krotulski, PhD; Melissa F. Fogarty, MS, D-ABFT-FT; Donna M. Papsun, MS, D-ABFT-FT; Michael Lamb, MS, D-ABFT-FT; Sara E. Walton, MS; and Barry K. Logan, PhD, F-ABFT

CFSRE; April 2022

Synthetic Cannabinoids in the United States: Trend Report: Q1, 2022

April 21, 2022April 21, 2022 Becky Carter

Alex J. Krotulski, PhD; Sara E. Walton, MS; Amanda L.A. Mohr, MSFS, D-ABFT-FT; and Barry K. Logan, PhD, F-ABFT

CFSRE; April 2022

Drug Checking Report – Q1 2022: Philadelphia, Pennsylvania, USA

March 24, 2022March 24, 2022 Becky Carter

Alex J. Krotulski, PhD; Jen Shinefeld, MS; Jeffrey Hom, MD, MPH; Sara E. Walton, MS; and Barry K. Logan, PhD, F-ABFT

CSFRE; March 22, 2022

N,N-Dimethylpentylone

January 5, 2022January 14, 2022 Becky Carter

Alex J. Krotulski, PhD; Sara E. Walton, MS; Melissa F. Fogarty, MSFS, DABFT-
FT; Donna M. Papsun, MS, D-ABFT; Barry K. Logan, PhD, F-ABFT

Center for Forensic Science Research and Education; December 17, 2021

Chemistry

Adverse Effects Linked to Next Generation Opioids Reported in Patients Presenting to Emergency Departments After Suspected Opioid Overdose

January 3, 2022January 14, 2022 Becky Carter

Alex Manini, MD; Alex J. Krotulski, PhD; Sara E. Walton, MS; Paul Wax, MD; Jeffery Brent, MD, PhD; Kim Aldy, DO; Diane Calello, MD; Alexandra Amaducci, DO; Evan Schwarz, MD; Bryan Judge, MD; Michael Levine, MD; Barry K. Logan, PhD, F-ABFT

Center for Forensic Science Research and Education; December 3, 2021

Read announcement

Forensic Pathology and Medicolegal Death Investigation, Seized Drugs/Controlled Substances, Toxicology

N-Piperidinyl Etonitazene

December 16, 2021January 14, 2022 Becky Carter

Alex J. Krotulski, PhD; Alex Manini, MD; Diane Calello, MD; Jeff Brent, MD, PhD; Paul Wax, MD; Kim Aldy, MD; Sara E. Walton, MS; Melissa F. Fogarty, MSFS, D-ABFT-FT; and Barry K. Logan, PhD, F-ABFT

Center for Forensic Science Research and Education; November 22, 2021

Chemistry

ADB-PHETINACA

December 16, 2021January 14, 2022 Becky Carter

Alex J. Krotulski, PhD; Alex Manini, MD; Diane Calello, MD; Jeff Brent, MD, PhD; Paul Wax, MD; Kim Aldy, MD; Sara E. Walton, MS; Melissa F. Fogarty, MSFS, D-ABFT-FT; and Barry K. Logan, PhD, F-ABFT

Center for Forensic Science Research and Education; November 19, 2021

Chemistry

BZO-CHMOXIZID

December 16, 2021January 14, 2022 Becky Carter

Alex J. Krotulski, PhD; Ryan Farrell; Amanda Mohaupt; Melissa F. Fogarty, MSFS, DABFT-
FT; and Barry K. Logan, PhD, F-ABFT

NPS Discovery, Center for Forensic Science Research and Education; November 18, 2021

Chemistry, Seized Drugs/Controlled Substances, Toxicology

ADB-FUBIATA

December 16, 2021January 14, 2022 Becky Carter

Alex J. Krotulski, PhD; Ryan Farrell; Kaitlin Schilde; Robert M. Schelkun, MS; Donna M. Iula, PhD; Melissa F. Fogarty, MSFS, D-ABFT-FT; and Barry K. Logan, PhD, F-ABFT

Center for Forensic Science Research and Education; November 17, 2021